{
  "paper_metadata": {
    "pmid": "39242501",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Mean age 56.8 years at onset, 58.6 years at diagnosis; 57.9% male.",
        "phenotype": "Coutinho stage 1 polyneuropathy ATTRv patients."
      },
      "penetrance_data": {
        "total_carriers_observed": 86,
        "affected_count": 19,
        "unaffected_count": 67,
        "uncertain_count": null,
        "penetrance_percentage": 22.09,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 67,
          "age_at_onset": 65,
          "age_at_diagnosis": 66,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Coutinho stage 1 polyneuropathy.",
          "evidence_sentence": "The mean age of patients at symptom onset was lower than the mean age at diagnosis, revealing a diagnosis delay of 1.8 years."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 59,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Coutinho stage 1 polyneuropathy.",
          "evidence_sentence": "Patients had a family history of ATTRv in 63.2% of cases."
        }
      ],
      "functional_data": {
        "summary": "The study involved complete sequencing of the TTR gene.",
        "assays": [
          "Complete sequencing",
          "Exon 2 analysis",
          "Exon 3 analysis",
          "Restriction fragment length polymorphism (RFLP)"
        ]
      },
      "segregation_data": "Segregates with disease in families as 63.2% of patients had a family history of ATTRv.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Table 2, Row 1",
      "additional_notes": "Val50Met was the most common mutation in both patients (84.2%) and asymptomatic carriers (77.9%).",
      "key_quotes": [
        "Val50Met was the most frequent mutation in both groups.",
        "Patients had a family history of ATTRv in 63.2% of cases."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Mean age 56.8 years at onset, 58.6 years at diagnosis; 57.9% male.",
        "phenotype": "Coutinho stage 1 polyneuropathy ATTRv patients."
      },
      "penetrance_data": {
        "total_carriers_observed": 86,
        "affected_count": 19,
        "unaffected_count": 67,
        "uncertain_count": null,
        "penetrance_percentage": 22.09,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 44,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "Asymptomatic carrier.",
          "evidence_sentence": "The study included 86 AC of a pathogenic mutation in the TTR gene."
        }
      ],
      "functional_data": {
        "summary": "The study involved complete sequencing of the TTR gene.",
        "assays": [
          "Complete sequencing",
          "Exon 2 analysis",
          "Exon 3 analysis",
          "Restriction fragment length polymorphism (RFLP)"
        ]
      },
      "segregation_data": "Segregates with disease in families as 63.2% of patients had a family history of ATTRv.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Table 2, Row 1",
      "additional_notes": "Val50Met was the most common mutation in both patients (84.2%) and asymptomatic carriers (77.9%).",
      "key_quotes": [
        "Val50Met was the most frequent mutation in both groups.",
        "Patients had a family history of ATTRv in 63.2% of cases."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Genotype distribution",
      "variants_extracted": 5
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data was consistent across multiple mentions of the same variants."
  }
}